Rejuvenate Bio
2 known investors
Rejuvenate Bio develops gene therapy treatments targeting the root causes of aging to address chronic diseases such as osteoarthritis, heart disease, and cancer in companion animals and humans.
BiotechHealthtechLongevity
Investors · 2
In the news
- Rejuvenate Bio’s Breakthrough: Extending Healthy Lives for Pets and Humanssuperpowers4good.com · 2026
- Rejuvenate Bio secures funding and Merck partnershiplongevity.technology · 2026
- Rejuvenate Bio Announces $6 Million Financing and Strategic R&D Collaboration with Merck Animal Healthbusinesswire.com · 2026
- Rejuvenate Bio Raises $6M in Financingfinsmes.com · 2026
- Rejuvenate Bio on Wefunder 2026 - Kingscrowdkingscrowd.com · 2026
- Rejuvenate Bio Raises Over $10M in Series A Funding for Gene Therapy Aging Treatment — Rejuvenate Biorejuvenatebio.com · 2021